NorthStar Realty Finance to Acquire Griffin-American

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
NorthStar Realty Finance to Acquire Griffin-American Healthcare REIT II in $4 Billion Transaction

IRVINE, Calif. and NEW YORK, Aug. 5, 2014 (GLOBE NEWSWIRE) -- Griffin-American Healthcare REIT II, Inc. ("Griffin-American") and NorthStar Realty Finance Corp. (NYSE: NRF ) ("NorthStar Realty") today announced that the boards of directors of both companies have unanimously approved a definitive merger agreement under which NorthStar Realty will acquire all of the outstanding shares of Griffin-American in a stock and cash transaction valued at $4 billion, or $11.50 per Griffin-American share.

Subject to the terms and conditions of the merger agreement, Griffin-American stockholders will receive: (i) $7.75 per share in cash; and (ii) $3.75 per share in NorthStar Realty common stock. The stock portion will be subject to a collar such that Griffin-American shareholders will receive 0.1859 NorthStar Realty shares if NorthStar Realty's stock price is above $20.17 per share at closing and 0.2344 NorthStar Realty shares if NorthStar Realty's stock price is below $16.00 at closing. If NorthStar Realty's stock price at closing is between $16.00 and $20.17 per share, Griffin shareholders will receive a number of NorthStar Realty shares between 0.1859 and 0.2344, equal to $3.75 in value.

"When we launched Griffin-American Healthcare REIT II nearly five years ago, we set out to build a premium portfolio of diversified healthcare real estate in order to provide investors with an opportunity to realize a compelling return on their investment," said Jeff Hanson, chairman and CEO of Griffin-American. "With this transaction, we have executed on our strategy, validating our investment thesis and delivering a strong result for stockholders."

Approvals and Timing

Completion of the Griffin-American transaction is subject to the approval of NorthStar Realty and Griffin-American shareholders and satisfaction of customary closing conditions. The transaction is expected to close in the fourth quarter of 2014.

Pending the closing of the transaction, the companies expect to pay customary common and preferred stock dividends with any necessary pro-rations through the actual closing date.

Advisors

BofA Merrill Lynch, Robert A. Stanger & Co., Inc. and KeyBanc Capital Markets Inc. acted as financial advisors to Griffin-American. Latham & Watkins LLP, McGuireWoods LLP and Morris, Manning & Martin LLP acted as legal advisors to Griffin-American. UBS Investment Bank and CS Capital Advisors are acting as financial advisors to NorthStar Realty, and Paul, Weiss, Rifkind, Wharton & Garrison LLP is acting as its legal counsel.

About Griffin-American Healthcare REIT II, Inc.

Griffin-American Healthcare REIT II, Inc. is a real estate investment trust organized to invest in a diversified portfolio of real estate properties, focusing primarily on medical office buildings and other healthcare-related facilities. The REIT is co-sponsored by American Healthcare Investors and Griffin Capital Corporation . For more information regarding Griffin-American Healthcare REIT II, please visit www.HealthcareREIT2.com .

About NorthStar Realty Finance Corp.

NorthStar Realty Finance Corp. ("NorthStar Realty") is a diversified commercial real estate investment company that is organized as a REIT. Northstar Realty is managed by an affiliate of NorthStar Asset Management Group Inc. (NYSE: NSAM ), a global asset management firm. For more information about NorthStar Realty, please visit www.nrfc.com .

Certain items in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which can be identified by words like "may," "should," "potential," "expect," "anticipate," "estimate," "believe," "could," "project," predict," "continue," "will," "would," "seek," "future," "intends" and similar expressions. These include statements about future results, including, among other things: the ability to consummate NorthStar Realty's proposed merger with Griffin-American on the terms proposed or at all. These statements are based on management's current expectations and beliefs and are subject to a number of trends and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements; Griffin-American can give no assurance that its expectations will be attained. Forward-looking statements are necessarily speculative in nature, and it can be expected that some or all of the assumptions underlying any forward-looking statements will not materialize or will vary significantly from actual results. Variations of assumptions and results may be material. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the definitive merger agreement; (2) the inability to complete the merger or failure to satisfy other conditions to completion of the merger; (3) the inability to complete the merger within the expected time period or at all, including due to the failure to obtain the Griffin-American stockholder approval, NorthStar Realty stockholder approval or the failure to satisfy other conditions to completion of the merger, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the merger; (4) risks related to disruption of management's attention from the ongoing business operations due to the proposed merger; (5) the effect of the announcement of the proposed mergers on NorthStar Realty's or Griffin-American's relationships with their respective customers, tenants, lenders, operating results and businesses generally; (6) the scalability of our investment platform, in particular, the healthcare real estate portfolio; (7) the size and timing of offerings or capital raises; and (8) the performance of Griffin's portfolio and NorthStar Realty's healthcare real estate portfolio generally. Additional factors that could cause actual results to differ materially from those in the forward-looking statements are specified in NorthStar Realty's Annual Report on Form 10-K for the year ended December 31, 2013, and its other filings with the Securities and Exchange Commission and Griffin-American's Annual Report on Form 10-K for the year ended December 31, 2013, and its other filings with the SEC. Such forward-looking statements speak only as of the date of this press release. Griffin-American expressly disclaims any obligation to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in its expectations with regard thereto or change in events, conditions or circumstances on which any statement is based.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities of NorthStar Realty.

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of materials of any vote or approval in respect of the proposed merger involving Griffin-American or otherwise. In connection with the proposed merger, a special stockholder meeting will be announced soon to obtain stockholder approval. In connection with the merger, NorthStar Realty intends to file with the Securities and Exchange Commission (the "SEC") a registration statement on Form S-4 that will include a joint proxy statement of Griffin-American and NorthStar Realty and that also constitutes a prospectus of NorthStar Realty. Griffin-American and NorthStar Realty also plan to file other relevant materials with the SEC. Investors and security holders of Griffin-American are urged to read the joint proxy statement/prospectus and other relevant materials when they become available because they will contain important information about Griffin-American, NorthStar Realty and the proposed transaction. The joint proxy statement/prospectus and other relevant materials (when they become available), and any other documents filed by Griffin-American with the SEC, may be obtained free of charge at the SEC's website at www.sec.gov , at Griffin-American's website at www.HealthcareREIT2.com or by sending a written request to Griffin-American at 18191 Von Karman Avenue, Suite 300, Irvine, California, Attention: Investor Relations.

Participants in the Solicitation

Griffin-American and its directors, executive officers and certain other members of management and employees may be deemed to be participants in soliciting proxies from the stockholders of Griffin-American in favor of the proposed merger. Information regarding the persons who may, under the rules of the SEC, be considered to be participants in the solicitation of Griffin-American's stockholders in connection with the proposed transaction and their ownership of Griffin-American's common stock will be set forth in Griffin-American's joint proxy statement for its special meeting. Investors can find more information about Griffin-American's executive officers and directors in its Annual Report on Form 10-K for the fiscal year ended December 31, 2013 and in its definitive proxy statement filed with the SEC on Schedule 14A on September 23, 2013.

Media Contact: Damon Elder (949) 270-9207

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Baccarat's Luxe Campaign Courts the High-End Traveler

Updated Category News Views 5

Shining the Spotlight on a Crystal-Clear Vision When Baccarat decides to cast its net over the high-end travel market, they're not doing it with subtlety. Nope, they're going all out, and why wouldn't they? When you've got a brand that's synonymous with luxury, you have to play the part. Enter Adriana Lima, the supermodel who could probably sell sand in the Maldives if...

Continue Reading
dMY IV Settlement: Investor Rights and Key Dates

Updated Category News Views 4

dMY IV Settlement: What You Need to Know Listen up, folks! If you've got a stake in dMY Technology Group, Inc. IV, there's big news brewing. We're talking class action, settlement talks, and a cool $11 million on the line. Let's crack open what this means for you as a holder of dMY IV Class A common stock during December 2021's whirlwind. Who Can Get a Piece of the...

Continue Reading
Electrolux Trends: Q3 '26 Shows Resilience Amid Challenges

Updated Category News Views 4

Electrolux's Strategic Moves In A Tough Market Electrolux's Q3 2026 paints a gritty picture—yet there's a pulse of resilience underneath the numbers. Net sales bumped up to SEK 33,919m due to a 3.5% organic growth, showing the company's ability to swim through choppy waters. But let's not brush aside the sharp rocks they’re dodging: soaring raw materials and logistics...

Continue Reading
Sunlife's Q3 2026 Results: Market Awaits Key Insights

Updated Category News Views 5

Sunlife Prepares to Unveil Third Quarter Performance Alright, folks, we're spinning the wheel again and betting on Sun Life Financial's (TSX: SLF) third quarter earnings, taking the spotlight on November 4, 2026. Anyone eyeballing this should circle their calendars, tie their shoelaces, and get prepared. Since they're laying out the details after the markets shut, looks...

Continue Reading
Middle East's Premier Jewellery Event: A Game-Changer

Updated Category News Views 4

An Event Gemmed with Strategic Importance The Middle East is about to see its streets glitter even more than usual. Next week, the Jewellery, Gem & Technology in Dubai (JGTD) event rolls into town, packed with brands that’ll drop in like swanky diamonds. We’re talking 300 heavy-duty exhibitors from all corners of the globe, ready to strut their stuff at the DEC Expo...

Continue Reading
Groundbreaking Sale: Lani Automotive Acquires Iowa Dealership

Updated Category News Views 9

A shift in the automotive retail world takes place with Lani Automotive Group's latest move. They've just picked up their first franchised dealership, Mount Pleasant Chevrolet GMC Chrysler Dodge Jeep Ram in Iowa. It's a mouthful, sure, but it packs a punch in terms of potential growth. Why This Sale Stands Out The deal was brokered by Performance Brokerage Services, which...

Continue Reading
Reverie Saigon Triumphs: Triple Acclaims in Global Awards

Updated Category News Views 5

A Celebration Beyond the Ordinary Now, if there's one thing the travel folks adore; it’s a hotel that isn’t just selling beds but an experience—a place where luxury meets soul. The Reverie Saigon in Ho Chi Minh City has snagged not one, but three prestigious accolades, and that’s worth more than just a passing glance. Exceptional Honors Across the Globe You...

Continue Reading
AceMyNursingExams Debuts Versatile Nursing Prep Platform

Updated Category News Views 5

A Digital Lifeline for Nursing Students Nursing students are buried in responsibilities: lectures, clinical rotations, and sometimes even a job to fund the whole marathon. And just when they think they’ve got it handled, boom, a mountain of exams rises up in front of them. AceMyNursingExams gets this, rolling out an online exam prep platform to keep these future...

Continue Reading
World Treadmill Championship: A New Run Begins

Updated Category News Views 7

A Run Like No Other I’ll bet you’ve heard it all when it comes to races—winding city marathons, grueling ultras with rough terrain, and everything in between. But a world championship on treadmills? Now that's a fresh spin! October 23rd, 2026 is when the RUN X™ World Treadmill Championship kicks off, stretching out across the planet in 400 fitness centres...

Continue Reading
Ziihera Extends Survival in Advanced GEA: Big Gains Ahead?

Updated Category News Views 3

A Hard Look at Ziihera's Three-Year Survival Story You know the drill—anytime a new drug pulls weight in the cancer arena, ears perk up. Jazz Pharmaceuticals' recent unveil at the 2026 ESMO Congress caught my attention like a solid run on the NASDAQ. We're looking at Ziihera, tangoing with tislelizumab and chemotherapy, hauling serious results against the nasty fight of...

Continue Reading

Top 5 Most Recently Viewed Articles

Keynote Speakers Announced for 2026 ISPE Aseptic Conference

Updated Category News Views 133

2026 ISPE Aseptic Conference Overview The upcoming 2026 ISPE Aseptic Conference is scheduled to take place in March and will welcome participants both in person and virtually. This important event will gather industry professionals, innovators, and regulators in a forum aimed at advancing the science and application of aseptic processing and sterile manufacturing. Keynote...

Continue Reading
Celebrating Cinema at the 20th China Film Huabiao Awards

Updated Category News Views 602

A Glimpse into the 20th China Film Huabiao Awards The eagerly anticipated 20th China Film Huabiao Awards is around the corner, taking place in a vibrant and artistic atmosphere. This ceremony not only celebrates individual achievements in the film industry but also marks a significant milestone for Chinese cinema, which has seen remarkable growth over the last century....

Continue Reading
Significant Growth in Optimism Coin Pricing and Activity

Updated Category News Views 90

Optimism (OP) Price Jumps Optimism, the OP token, has stepped into the spotlight with a sharp daily move: up 6.48% in the last 24 hours to $1.60. That daily rise builds on a strong week, where OP climbed more than 17.0%, moving from $1.36 to its current level. Placed against its all-time high of $4.84, today’s price sits well below the peak, a reminder of how far the...

Continue Reading
What Investors Should Know About Annaly Capital Management Now

Updated Category News Views 169

Annaly Capital Management's Upcoming Earnings Report Annaly Capital Management (NYSE:NLY) is scheduled to release its quarterly earnings report soon. Investors are eager to find out how the company is performing and what it might mean for future investments. Analysts predict an earnings per share (EPS) of $0.72, and there is hope that the company will not only meet but...

Continue Reading
UBS Group's Remarkable Performance and Growth Over 5 Years

Updated Category News Views 264

UBS Group: A Powerhouse on the Financial Scene In an era where stock performances often leave investors scratching their heads, UBS Group (NYSE: UBS) has carved out a prominent niche with its stellar market growth. Over the past five years, this banking giant has not just weathered economic storms; it’s thrived, boasting an annual growth rate that surpasses the general...

Continue Reading